In vitro safety assessments and antimicrobial activities of Lactobacillus rhamnosus strains isolated from a fermented mare's milk

Animal Science Journal

Volumn 88, Issue 3, 2017, Pages 517-525

  Aryantini, Ni Putu Desy ^a   Yamasaki, Eiki ^a   Kurazono, Hisao ^a   Sujaya, I Nengah ^b   Urashima, Tadasu ^a   Fukuda, Kenji ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b UDAYANA UNIVERSITY   (Indonesia)

Author keywords

antibacterial activity; fermented Sumbawa mare's milk; food safety

Indexed keywords

ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ANIMAL; ANTIBIOSIS; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; FEMALE; FERMENTED MILK PRODUCT; FOOD SAFETY; HORSE; ISOLATION AND PURIFICATION; LACTOBACILLUS RHAMNOSUS; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; CULTURED MILK PRODUCTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MICROBIAL; FEMALE; FOOD SAFETY; HORSES; LACTOBACILLUS RHAMNOSUS; PROBIOTICS;

EID: 84994435908     PISSN: 13443941     EISSN: 17400929     Source Type: Journal    
DOI: 10.1111/asj.12668     Document Type: Article

References (36)

1. Batdorj B, Dalgalarrondo M, Choiset Y, Pedroche J, Métro F, Prévost H, et al. 2006. Purification and characterization of two bacteriocins produced by lactic acid bacteria isolated from Mongolian airag. Journal of Applied Microbiology 101, 837–848.
2. Begley M, Hill C, Gahan CGM. 2006. Bile salt hydrolase activity in probiotics. Applied and Environmental Microbiology 72, 1729–1738.
3. Begovic J, Huys G, Mayo B, D'Haene K, Florez AB, Lozo J, et al. 2009. Human vaginal Lactobacillus rhamnosus harbor mutation in 23S rRNA associated with erythromycin resistance. Research in Microbiology 160, 421–426.
4. Bergmann S, Rohde M, Preissner KT, Hammerschmidt S. 2005. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration. Thrombosis and Haemostasis 94, 304–311.
5. Bernardeau M, Vernoux JP, Henri-Dubernet S, Guéguen M. 2008. Safety assessment of dairy microorganisms: the Lactobacillus genus. International Journal of Food Microbiology 126, 278–285.
6. Chen Y, Wang Z, Chen X, Liu Y, Zhang H, Sun T. 2010. Identification of angiotensin I-converting enzyme inhibitory peptides from koumiss, a traditional fermented mare's milk. Journal of Dairy Science 93, 884–892.
7. Collado MC, Meriluoto J, Salminen S. 2008. Adhesion and aggregation properties of probiotic and pathogen strains. European Food Research and Technology 226, 1065–1073.
8. Dubois M, Gills KA, Hamilton JK, Robert PA, Smith F. 1956. Colorimetric method for determination of sugars and related substances. Analytical Chemistry 28, 350–356.
9. European Food Safety Authority (EFSA). 2012. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary important. EFSA Journal 10, 1–10.
10. FAO/WHO. 2002. Guidelines for the evaluation of probiotic in food. Report of a joint FAO/WHO working group on drafting guidelines for evaluation of probiotic in food. FAO/WHO, London Ontario, Canada.
11. Handley PS, Harty DWS, Wyatt JE, Brown CR, Doran JP, Gibbs ACC. 1987. A comparison of the adhesion, coaggregation and cell-surface hydrophobicity properties of fibrillar and fimbriate strains of Streptococcus salivarius. Journal of General Microbiology 133, 3207–3217.
12. Hurmalainen V, Edelman S, Antikainen J, Baumann M, Lähteenmäki K, Korhonen TK. 2007. Extracellular proteins of Lactobacillus crispatus enhance activation of human plasminogen. Microbiology 153, 1112–1122.
13. Ishibashi N, Yamazaki S. 2001. Probiotics and safety. American Journal of Clinical Nutrition 73, 465S–470S.
14. ISO 10932/IDF 223. 2010. Milk and milk product-determination of minimal inhibitory concentration (MIC) of antibiotic applicable to bifidobacteria and non-enterococcal lactic acid bacteria (LAB).
15. Keersmaecker SCJD, Verhoeven TLA, Desair J, Marchal K, Vanderleyden J, Nagy I. 2006. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella typhimurium is due to accumulation of lactic acid. FEMS Microbiology 259, 89–96.
16. Kõll P, Mändar R, Smidt I, Hütt P, Truusalu K, Mikelsaar RH, et al. 2010. Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics. Current Microbiology 61, 560–566.
17. Kurdi P, Tanaka H, Van Veen HW, Asano K, Tomita F, Yokota A. 2003. Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria. Microbiology 149, 2031–2037.
18. Lähteenmäki K, Edelman S, Korhonen TK. 2005. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends in Microbiology 13, 79–85.
19. Lähteenmäki K, Kuusela P, Korhonen TK. 2001. Bacterial plasminogen activators and receptors. FEMS Microbiology Reviews 25, 531–552.
20. Leclercq R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clinical Infectious Diseases 34, 482–492.
21. Maragkoudakis PA, Zoumpopoulou G, Miaris C, Kalantzopoulos G, Pot B, Tsakalidou E. 2006. Probiotic potential of Lactobacillus strains isolated from dairy products. International Dairy Journal 16, 189–199.
22. Miller RS, Hoskins LC. 1981. Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method. Gastroenterology 81, 759–765.
23. Oakey HJ, Harty DWS, Knox KW. 1995. Enzyme production by lactobacilli and the potential link with infective endocarditis. Journal of Applied Bacteriology 78, 142–148.
24. Potočnik K, Gantner V, Kuterovac K, Cividini A. 2011. Mare's milk: composition and protein fraction in comparison with different milk species. Mljekarstvo 61, 107–113.
25. Rabe LK, Hillier SL. 2003. Optimization of media for detection of hydrogen peroxide production by Lactobacillus species. Journal of Clinical Microbiology 41, 3260–3264.
26. Rodrigues da Cunha L, Fortes Ferreira CL, Durmaz E, Goh YJ, Sanozky-Dawes R, Klaenhammer T. 2012. Characterization of Lactobacillus gasseri isolates from a breast-fed infant. Gut Microbes 3, 15–24.
27. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, et al. 2004. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clinical Infectious Diseases 38, 62–69.
28. Salminen S, Isolauri E, Salminen E. 1996. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 70, 347–358.
29. Shi T, Nishiyama K, Nakamata K, Aryantini NPD, Mikumo D, Oda Y, et al. 2012. Isolation of potential probiotic Lactobacillus rhamnosus strains from traditional fermented mare milk produced in Sumbawa Island of Indonesia. Bioscience, Biotechnology, and Biochemistry 76, 1897–1903.
30. Solieri L, Bianchi A, Mottolese G, Lemmetti F, Giudici P. 2014. Tailoring the probiotic potential of non-starter Lactobacillus strains from ripened Parmigiano Reggiano cheese by in vitro screening and principal component analysis. Food Microbiology 38, 240–249.
31. Sperandio D, Rossignol G, Guerillon J, Connil N, Orange N, Feuilloley MGJ, et al. 2010. Cell-associated hemolysis activity in the clinical strain of Pseudomonas fluorescens MFN1032. BMC Microbiology 10, 1–11.
32. Vesterlund S, Vankerckhoven V, Saxelin M, Goossens H, Salminen S, Ouwehand AC. 2007. Safety assessment of Lactobacillus strains: Presence of putative risk factors in faecal, blood and probiotic isolates. International Journal of Food Microbiology 116, 325–331.
33. Waśko A, Skrzypczak K, Polak-Berecka M, Kuzdralinski A. 2012. Genetic mechanisms of variation in erythromycin resistance in Lactobacillus rhamnosus strains. Journal of Antibiotics 65, 583–586.
34. Wakil SM, Osamwonyi UO. 2012. Isolation and screening of antimicrobial producing lactic acid bacteria from fermentating millet gruel. International Research Journal of Microbiology 3, 72–79.
35. Wollowski I, Rechkemmer G, Pool-Zobel BL. 2001. Protective role of probiotics and prebiotics in colon cancer. American Journal of Clinical Nutrition 73, 451S–455S.
36. Zhou JS, Gopal PK, Gill HS. 2001. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. International Journal of Food Microbiology 63, 81–90.